Back to mobile site

Stephens Reiterates Overweight Rating on Myriad Genetics (MYGN)

April 5, 2019 9:59 AM EDT Send to a Friend
Stephens analyst Drew Jones reiterated an Overweight rating and $52.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login